Specialty Chemicals firm Camlin Fine Sciences announced Q1FY23 Result : Q1FY23 Revenues constant despite shutdown of Diphenol Plant at Dahej for 4 weeks. Robust growth in Blends business continues Increase in Operational EBITDA despite higher energy cost in CFS Europe continuing in current quarter Energy cost in subsidiary CFS Europe SpA, Italy remained at high level due to Russia-Ukraine conflict. For Q1 FY 23, the said costs were higher by Rs. 47.8 mn as compared to Q4 FY22 and Rs. 255.8 mn as compared to Q1 FY22. The impact has been recovered to some extent by increase in selling prices during Q1 FY23 and Q4 FY22. Capital expansion plan of Methyl / Ethyl Vanillin is in final stage, commercial production expected in near future Debottlenecking of Diphenol Plant completed in May'22, capacity enhanced to 15,000 MT from 10,000 MT Result PDF
Specialty Chemicals company Camlin Fine Sciences declares Q3FY22 result: Revenue grows QoQ grows by 22.4% fueled by robust demand Gross margin improves by 166 bps QoQ to 46.7% despite the inflationary trend in raw material and logistic costs EBITDA margin improves by 719 bps QoQ to 14.5% Sustained performance despite annual maintenance shut down in Diphenol Plant in Europe for four weeks One-time reversal of export benefit under MEIS Scheme of INR 3.98 crore on withdrawal of the Scheme by Government CAPEX program on track with Ethyl / Methyl Vanillin Plant at Dahej SEZ expected to achieve mechanical completion in March 2022 and commercial production in June / July 2022 Result PDF